Mirikizumab ELISA Kit
Product Specifications
Background
Mirikizumab (Eli Lilly and Company), Risankizumab (Boehringer Ingelheim and AbbVie), Tildrakizumab (Sun Pharma), Brazikumab (AstraZeneca), and Guselkumab (Janssen Biotech Inc.) are other drugs which target IL-23 and received the FDA approval for the treatment of psoriasis.
Specifications
Mirikizumab
Product Name Alternative
LY-3074828, CAS: 1884201-71-1
Detection Method
Colorimetric
Assay Type
Quantitative
Sample Type
Plasma, Serum
Detection Range
0.31-5 μg/mL
Recovery
80-120%
Sensitivity
0.156 μg/ml
Shipping Conditions
2-8 °C
Storage Conditions
The stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition.
Notes
For Research Use Only.
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6167820-01 0.1 mL
HES1 (Hairy and Enhancer of Split 1, (Drosophila), FLJ20408, HES-1, HHL, HRY, bHLHb39) (APC)
Ask
View Details